The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Susan E. Bates

9000 Rockville Pike

Building 10 Room 12N226

Bethesda

Maryland 20892

USA

[email]@helix.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • 9000 Rockville Pike, Building 10 Room 12N226, Bethesda, Maryland 20892, USA. 2011 - 2012
  • Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA. 2001 - 2012
  • Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA. 2001 - 2009

References

  1. A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1(R) in Combination With Paclitaxel in Solid Tumors. Kelly, R.J., Robey, R.W., Chen, C.C., Draper, D., Luchenko, V., Barnett, D., Oldham, R.K., Caluag, Z., Frye, A.R., Steinberg, S.M., Fojo, T., Bates, S.E. Oncologist (2012) [Pubmed]
  2. Drug development: portals of discovery. Bates, S.E., Amiri-Kordestani, L., Giaccone, G. Clin. Cancer Res. (2012) [Pubmed]
  3. The Challenge of Exploiting ABCG2 in the Clinic. Robey, R.W., Ierano, C., Zhan, Z., Bates, S.E. Curr. Pharm. Biotechnol (2011) [Pubmed]
  4. Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma. Bates, S.E., Zhan, Z., Steadman, K., Obrzut, T., Luchenko, V., Frye, R., Robey, R.W., Turner, M., Gardner, E.R., Figg, W.D., Steinberg, S.M., Ling, A., Fojo, T., To, K.W., Piekarz, R.L. Br. J. Haematol. (2010) [Pubmed]
  5. Commentary: troublesome words, linguistic precision, and medical oncology. Bates, S.E., Benz, E.J. Oncologist (2009) [Pubmed]
  6. Histone deacetylase inhibitors in combinations: will the preclinical promises be kept?. Bates, S.E., Piekarz, R.L. Cancer. J (2007) [Pubmed]
  7. ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins. Bates, S.E., Medina-Pérez, W.Y., Kohlhagen, G., Antony, S., Nadjem, T., Robey, R.W., Pommier, Y. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  8. A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Bates, S.E., Bakke, S., Kang, M., Robey, R.W., Zhai, S., Thambi, P., Chen, C.C., Patil, S., Smith, T., Steinberg, S.M., Merino, M., Goldspiel, B., Meadows, B., Stein, W.D., Choyke, P., Balis, F., Figg, W.D., Fojo, T. Clin. Cancer Res. (2004) [Pubmed]
  9. A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar). Bates, S., Kang, M., Meadows, B., Bakke, S., Choyke, P., Merino, M., Goldspiel, B., Chico, I., Smith, T., Chen, C., Robey, R., Bergan, R., Figg, W.D., Fojo, T. Cancer (2001) [Pubmed]
  10. The role of half-transporters in multidrug resistance. Bates, S.E., Robey, R., Miyake, K., Rao, K., Ross, D.D., Litman, T. J. Bioenerg. Biomembr. (2001) [Pubmed]
 
WikiGenes - Universities